These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11185464)

  • 21. Reply: To PMID 24259282.
    Youssof S; Spafford M
    Muscle Nerve; 2014 Nov; 50(5):870-1. PubMed ID: 25155195
    [No Abstract]   [Full Text] [Related]  

  • 22. Dysphagia from esophageal diverticulosis responding to botulinum toxin injection.
    DeVault KR
    Am J Gastroenterol; 1997 May; 92(5):895-7. PubMed ID: 9149211
    [No Abstract]   [Full Text] [Related]  

  • 23. Premortem examination of the cricopharyngeus muscle in oculopharyngeal muscular dystrophy: inflammatory cells and tubular aggregates--case report.
    Watters MR; Herbers JE
    Mil Med; 1985 Dec; 150(12):686-8. PubMed ID: 3935975
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrasound-Guided Injection of Botulinum Toxin for Cricopharyngeal Dysphagia.
    Wang YC; Shyu SG; Wu CH; Wang TG
    Am J Phys Med Rehabil; 2018 Oct; 97(10):e102-e103. PubMed ID: 29757765
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in the pharyngeal and esophageal musculature in oculopharyngeal muscular dystrophy. Report of 2 cases.
    Weitzner S
    Am J Dig Dis; 1969 Nov; 14(11):805-10. PubMed ID: 5358882
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin for cricopharyngeal dysphagia: case reports of CT-guided injection.
    Atkinson SI; Rees J
    J Otolaryngol; 1997 Aug; 26(4):273-6. PubMed ID: 9263899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper esophageal sphincter myotomy in oculopharyngeal muscular dystrophy: long-term clinical results.
    Fradet G; Pouliot D; Robichaud R; St-Pierre S; Bouchard JP
    Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S90-5. PubMed ID: 9392024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oculopharyngeal muscular dystrophy treated by inferior constrictor myotomy.
    Montgomery WW; Lynch JP
    Trans Am Acad Ophthalmol Otolaryngol; 1971; 75(5):986-93. PubMed ID: 5097831
    [No Abstract]   [Full Text] [Related]  

  • 29. Noncosmetic uses of botulinum toxin in otolaryngology.
    Benninger MS; Smith LJ
    Cleve Clin J Med; 2015 Nov; 82(11):729-32. PubMed ID: 26540323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The oculopharyngeal muscular dystrophy (author's transl)].
    Hartmann A; Berendes K
    Nervenarzt; 1979 Dec; 50(12):788-93. PubMed ID: 547188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oculopharyngeal myopathy].
    Desnos J; Dubin J; Boutin J; Bornhauser X
    Rev Laryngol Otol Rhinol (Bord); 1978; 99(1-2):111-28. PubMed ID: 674924
    [No Abstract]   [Full Text] [Related]  

  • 32. Oculopharyngeal muscular dystrophy.
    Johnson CC; Kuwabara T
    Am J Ophthalmol; 1974 Jun; 77(6):872-9. PubMed ID: 4833876
    [No Abstract]   [Full Text] [Related]  

  • 33. Late-onset muscle dystrophy: oculopharyngoesophageal variety.
    Lewis I
    Can Med Assoc J; 1966 Jul; 95(4):146-50. PubMed ID: 5940325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin in nonachalasia motility disorders: a welcomed therapy in an area with limited therapeutic options.
    Vaezi MF
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1122-4. PubMed ID: 23602825
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dysphagia in oculopharyngeal myopathies. Report of 7 cases].
    Lacau St Guily J; Baril P; Tome F; Chaussade S; Ponsot P
    Ann Otolaryngol Chir Cervicofac; 1990; 107(8):542-6. PubMed ID: 2085257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids.
    VICTOR M; HAYES R; ADAMS RD
    N Engl J Med; 1962 Dec; 267():1267-72. PubMed ID: 13997067
    [No Abstract]   [Full Text] [Related]  

  • 37. Inflammatory myopathy in oculopharyngeal dystrophy.
    Bosch EP; Gowans JD; Munsat T
    Muscle Nerve; 1979; 2(1):73-7. PubMed ID: 545144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method.
    Schneider I; Thumfart WF; Pototschnig C; Eckel HE
    Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):31-5. PubMed ID: 8291857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Digestive disorders in Parkinson's disease: dysphagia and sialorrhea].
    González-Fernández J; Prieto-Albin R; Velasco-Palacios L; Jorge-Roldán S; Cubo-Delgado E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S51-4. PubMed ID: 20205142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oculopharyngeal muscular dystrophy.
    Penchaszadeh V; Teasdall RD
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):118. PubMed ID: 5173121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.